EQ Labs Reduces Manufacturing Costs and Increases Operating Efficiencies

LAS VEGAS, Feb. 18 /PRNewswire-FirstCall/ -- EQ Labs, Inc. (Pink Sheets: EQLB), a manufacturer and distributor of the EQ Smart Energy Drink®  effervescent tablets, announced today that it has entered into a partnership with one of the world's largest private label tablet manufacturers who has the capacity to produce one million EQ drink tablets per day. This relationship will result in reduced labor and transportation costs and quicker turnaround times for reorders placed by the Company's distributors and brokers.

"The Company has recently taken measures to enhance our operating efficiencies in order to meet the growing demand for our products, which now come in recyclable plastic tubes and individual biodegradable packets," Maurice "Mo" Owens, the CEO of EQ Labs stated.  "By entering into this  new manufacturing partnership, we'll be reducing the number of steps required in the manufacturing and distribution processes and should be able to increase our gross profit margin by 25%. Owens continued, "All of us believe this new operating model will enable us to step up our game and realize our goal of acquiring a competitive share of the energy drink market."

About EQ Labs, Inc. EQ Labs Smart Energy Drink™ is an effervescent tablet that provides instant energy to any beverage. Consisting of a blend of essential vitamins, Gingko Biloba, and less caffeine than a cup of coffee, EQ keeps you going any time -- day or night. For more information about EQ, visit: www.drinkeq.com.

Forward-Looking Statements: This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by EQ Labs, Inc. are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance, or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

SOURCE EQ Labs, Inc.